Hno

Hno

SCHEMBL6534953

Cl.Cl.Cl.N=O.[Ru]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hno. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hno SCHEMBL3036045 0.89
Hno SCHEMBL9342219 0.89
Hno SCHEMBL168461 0.89
Hno SCHEMBL9340257 0.89
Hno SCHEMBL28136677 0.80
Hno SCHEMBL27460527 0.80
Hno SCHEMBL2311435 0.80
Hno SCHEMBL14889227 0.78
Hno SCHEMBL7785053 0.78
Hno SCHEMBL8928095 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112142127-A Method for preparing ruthenium nitrosyl nitrate solution 中国船舶重工集团公司第七一八研究所 2020-12-29 CN disclosed
EP-0830161-B1 NITRIC OXIDE-RELEASING NITROSO COMPOSITIONS AND METHODS AND INTRAVASCULAR DEVICES FOR USING THEM TO PREVENT RESTENOSIS NOVOVASCULAR INC (US) 2004-07-28 EP disclosed
EP-0975274-A4 INHIBITION OF BLOOD PLATELET AGGREGATION IN BLOOD EXPOSED TO A FOREIGN BODY BY A POLYMER COATING ON THE SURFACE THEREOF CONTAINING A NITRIC OXIDE-RELEASING NITROSYL-CONTAINING ORGANOMETALLIC COMPOUND AND FOREIGN BODIES THUS COATED NOVO VASC L L C (US) 2004-05-19 EP disclosed
EP-0700378-B1 COMPOUNDS WHICH RELEASE NITRIC OXIDE UNIV CALIFORNIA (US) 2000-12-20 EP disclosed
EP-0830161-A4 NITRIC OXIDE-RELEASING NITROSO COMPOSITIONS AND METHODS AND INTRAVASCULAR DEVICES FOR USING THEM TO PREVENT RESTENOSIS NOVOVASC LLC (US) 2000-08-02 EP disclosed
EP-0975274-A2 INHIBITION OF BLOOD PLATELET AGGREGATION IN BLOOD EXPOSED TO A FOREIGN BODY BY A POLYMER COATING ON THE SURFACE THEREOF CONTAINING A NITRIC OXIDE-RELEASING NITROSYL-CONTAINING ORGANOMETALLIC COMPOUND AND FOREIGN BODIES THUS COATED Novo Vasc, L.L.C. (US) 2000-02-02 EP disclosed
US-5797887-A Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation NOVOVASC LLC (US) 1998-08-25 US disclosed
EP-0830161-A1 NITRIC OXIDE-RELEASING NITROSO COMPOSITIONS AND METHODS AND INTRAVASCULAR DEVICES FOR USING THEM TO PREVENT RESTENOSIS Nitrosci Pharmaceuticals, LLC (US) 1998-03-25 EP disclosed
WO-1998008482-A2 POLYMERIC COATING FOR A SURFACE EXPOSED TO BLOOD NOVO VASC, L.L.C. (US) 1998-03-05 WO disclosed
US-5665077-A Nitric oxide-releasing nitroso compositions and methods and intravascular devices for using them to prevent restenosis NITROSCI PHARMACEUTICALS LLC (US) 1997-09-09 US disclosed
WO-1996033757-A1 NITRIC OXIDE-RELEASING NITROSO COMPOSITIONS AND METHODS AND INTRAVASCULAR DEVICES FOR USING THEM TO PREVENT RESTENOSIS NITROSCI PHARMACEUTICALS, LLC (US) 1996-10-31 WO disclosed
EP-0700378-A1 COMPOUNDS WHICH RELEASE NITRIC OXIDE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1996-03-13 EP disclosed
EP-0700378-A4 COMPOUNDS WHICH RELEASE NITRIC OXIDE UNIV CALIFORNIA (US) 1996-01-22 EP disclosed
US-5374710-A Compounds which release nitric oxide upon illumination REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-12-20 US disclosed
WO-1994027957-A1 COMPOUNDS WHICH RELEASE NITRIC OXIDE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1994-12-08 WO disclosed